A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study

ERJ Open Res. 2022 May 30;8(2):00129-2022. doi: 10.1183/23120541.00129-2022. eCollection 2022 Apr.

Abstract

This study suggests caution when prescribing systemic corticosteroids to patients with #COVID19 who show mild-to-moderate pulmonary symptoms because a harmful effect cannot be excluded https://bit.ly/3P4nOjQ.